The incidence of the cancer has doubled over the past 25 years. But it's also a disease without a public profile, which means ...

Analysis of health records revealed a reduced incidence of breast cancer among women using GLP-1 medications. The results do ...

NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion ...

On the occasion of World Environment Day, it is important to highlight the close connection between environmental pollution ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

Ona Therapeutics, a Barcelona-based drugmaker, is developing next-generation drugs it says could help patients with advanced ...

Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable ...

Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest ...

The 39th Annual Oswego Health Foundation Golf Tournament, held June 1 at the Oswego Country Club, raised more than $147,000 to support local patient care and expand access to ...

A major new study has uncovered a connection between GLP-1 agonists, medication prescribed for weight loss and diabetes ...

Our Phase 2 design reflects both the translational science and the realities of ALS by integrating validated biomarkers such as neurofilament light chain alongside clinically meaningful endpoints,” ...

New research has found that persons living with breast, lung, bowel and liver cancers who take GLP-1 weight-loss drugs may be ...